0001969171-24-000021.txt : 20240510 0001969171-24-000021.hdr.sgml : 20240510 20240510124007 ACCESSION NUMBER: 0001969171-24-000021 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 263744114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38583 FILM NUMBER: 24933814 BUSINESS ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-450-6464 MAIL ADDRESS: STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Betz Stephen F. CENTRAL INDEX KEY: 0001886575 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 10222 BARNES CANYON ROAD STREET 2: BUILDING 2 CITY: SAN DIEGO STATE: CA ZIP: 92121 144 1 primary_doc.xml 144 0001886575 XXXXXXXX LIVE 0001658247 Crinetics Pharmaceuticals, Inc. 001-38583 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464 Betz Stephen F. Officer Co-Founder Common Ameriprise Financial

2865 Ameriprise Financial Center Minneapolis MN 55474

3000 148290.00 78859510 05/10/2024 NASDAQ Common 03/16/2015 Purchased on open market N/A N 3000 03/16/2015 Cash Y Shares sold were sold pursuant to a Rule 10B5-1 trading plan 05/10/2024 08/25/2023 /s/ Alexander Meginnes as a duly authorized representative of Ameriprise Financial Services Inc, as attorney-in-fact for Stephen Betz